

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of neurotransmitter secretion (GO:0046929) | 8.49895384 |
| 2 | negative regulation of neurotransmitter transport (GO:0051589) | 5.63807587 |
| 3 | phospholipid scrambling (GO:0017121) | 5.48908824 |
| 4 | negative regulation of amino acid transport (GO:0051956) | 4.88097335 |
| 5 | positive regulation of amino acid transport (GO:0051957) | 4.64138426 |
| 6 | positive regulation of catecholamine secretion (GO:0033605) | 4.58121514 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 4.32520819 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.32520819 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 4.00077034 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.00077034 |
| 11 | desmosome organization (GO:0002934) | 3.97720083 |
| 12 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.91218841 |
| 13 | protein carboxylation (GO:0018214) | 3.91218841 |
| 14 | aromatic amino acid family catabolic process (GO:0009074) | 3.86803685 |
| 15 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.84309109 |
| 16 | intestinal epithelial cell development (GO:0060576) | 3.77894146 |
| 17 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.69649876 |
| 18 | mannose metabolic process (GO:0006013) | 3.65505289 |
| 19 | regulation of glutamate secretion (GO:0014048) | 3.62762312 |
| 20 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.61601148 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 3.58253282 |
| 22 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 3.54687705 |
| 23 | complement activation, alternative pathway (GO:0006957) | 3.51541682 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 3.50097462 |
| 25 | negative regulation of organic acid transport (GO:0032891) | 3.49618373 |
| 26 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.46249093 |
| 27 | indole-containing compound catabolic process (GO:0042436) | 3.41292728 |
| 28 | indolalkylamine catabolic process (GO:0046218) | 3.41292728 |
| 29 | tryptophan catabolic process (GO:0006569) | 3.41292728 |
| 30 | regulation of fibrinolysis (GO:0051917) | 3.34570139 |
| 31 | bile acid biosynthetic process (GO:0006699) | 3.33642851 |
| 32 | plasma lipoprotein particle clearance (GO:0034381) | 3.33489131 |
| 33 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.33291363 |
| 34 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.33291363 |
| 35 | keratinocyte proliferation (GO:0043616) | 3.31282751 |
| 36 | regulation of protein activation cascade (GO:2000257) | 3.30775814 |
| 37 | tryptophan metabolic process (GO:0006568) | 3.30741485 |
| 38 | fibrinolysis (GO:0042730) | 3.25431475 |
| 39 | kynurenine metabolic process (GO:0070189) | 3.25359119 |
| 40 | early endosome to late endosome transport (GO:0045022) | 3.24426640 |
| 41 | regulation of membrane lipid distribution (GO:0097035) | 3.24399644 |
| 42 | high-density lipoprotein particle remodeling (GO:0034375) | 3.23985114 |
| 43 | urea metabolic process (GO:0019627) | 3.20790265 |
| 44 | urea cycle (GO:0000050) | 3.20790265 |
| 45 | phospholipid efflux (GO:0033700) | 3.14990112 |
| 46 | hypotonic response (GO:0006971) | 3.13870710 |
| 47 | regulation of Rac protein signal transduction (GO:0035020) | 3.12939594 |
| 48 | regulation of complement activation (GO:0030449) | 3.12363173 |
| 49 | hemidesmosome assembly (GO:0031581) | 3.09873251 |
| 50 | cysteine metabolic process (GO:0006534) | 3.03602024 |
| 51 | nuclear pore complex assembly (GO:0051292) | 3.03166314 |
| 52 | phospholipid translocation (GO:0045332) | 3.01055220 |
| 53 | lipid translocation (GO:0034204) | 3.01055220 |
| 54 | reverse cholesterol transport (GO:0043691) | 3.00408465 |
| 55 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.97360366 |
| 56 | regulation of triglyceride catabolic process (GO:0010896) | 2.95000271 |
| 57 | cellular glucuronidation (GO:0052695) | 2.92812296 |
| 58 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.92718827 |
| 59 | glyoxylate metabolic process (GO:0046487) | 2.91351058 |
| 60 | nerve growth factor signaling pathway (GO:0038180) | 2.90777367 |
| 61 | tyrosine metabolic process (GO:0006570) | 2.85340967 |
| 62 | growth hormone receptor signaling pathway (GO:0060396) | 2.84704527 |
| 63 | Rap protein signal transduction (GO:0032486) | 2.84075285 |
| 64 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.84020954 |
| 65 | nitrogen cycle metabolic process (GO:0071941) | 2.82596695 |
| 66 | cholesterol efflux (GO:0033344) | 2.81846696 |
| 67 | protein-lipid complex remodeling (GO:0034368) | 2.81287893 |
| 68 | macromolecular complex remodeling (GO:0034367) | 2.81287893 |
| 69 | plasma lipoprotein particle remodeling (GO:0034369) | 2.81287893 |
| 70 | acute-phase response (GO:0006953) | 2.78684143 |
| 71 | phospholipid homeostasis (GO:0055091) | 2.77372197 |
| 72 | opsonization (GO:0008228) | 2.75966676 |
| 73 | bile acid metabolic process (GO:0008206) | 2.75902192 |
| 74 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.75880819 |
| 75 | sulfur amino acid catabolic process (GO:0000098) | 2.75718203 |
| 76 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.73345108 |
| 77 | triglyceride homeostasis (GO:0070328) | 2.72956193 |
| 78 | acylglycerol homeostasis (GO:0055090) | 2.72956193 |
| 79 | homocysteine metabolic process (GO:0050667) | 2.72678823 |
| 80 | positive regulation of lipid catabolic process (GO:0050996) | 2.72039650 |
| 81 | positive regulation of blood coagulation (GO:0030194) | 2.71974636 |
| 82 | positive regulation of hemostasis (GO:1900048) | 2.71974636 |
| 83 | negative regulation of cholesterol transport (GO:0032375) | 2.70183232 |
| 84 | negative regulation of sterol transport (GO:0032372) | 2.70183232 |
| 85 | plasma lipoprotein particle assembly (GO:0034377) | 2.68871899 |
| 86 | low-density lipoprotein particle clearance (GO:0034383) | 2.68513746 |
| 87 | protein-lipid complex assembly (GO:0065005) | 2.66598313 |
| 88 | negative regulation of amine transport (GO:0051953) | 2.65974779 |
| 89 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.65817456 |
| 90 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 2.65757377 |
| 91 | smooth muscle tissue development (GO:0048745) | 2.65587180 |
| 92 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.64952082 |
| 93 | positive regulation of coagulation (GO:0050820) | 2.64813802 |
| 94 | cell adhesion mediated by integrin (GO:0033627) | 2.64446334 |
| 95 | aromatic amino acid family metabolic process (GO:0009072) | 2.63971787 |
| 96 | peptidyl-threonine modification (GO:0018210) | 2.63869706 |
| 97 | peptidyl-threonine phosphorylation (GO:0018107) | 2.59921831 |
| 98 | regulation of cholesterol esterification (GO:0010872) | 2.59184507 |
| 99 | uronic acid metabolic process (GO:0006063) | 2.58993252 |
| 100 | glucuronate metabolic process (GO:0019585) | 2.58993252 |
| 101 | gland morphogenesis (GO:0022612) | 2.58847398 |
| 102 | nuclear pore organization (GO:0006999) | 2.58724193 |
| 103 | regulation of cholesterol storage (GO:0010885) | 2.56310237 |
| 104 | negative regulation of lipid storage (GO:0010888) | 2.55361078 |
| 105 | actin filament capping (GO:0051693) | 2.53988696 |
| 106 | regulation of cholesterol homeostasis (GO:2000188) | 2.53574914 |
| 107 | cellular response to ethanol (GO:0071361) | 2.52670441 |
| 108 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.52603634 |
| 109 | gap junction assembly (GO:0016264) | 2.52409529 |
| 110 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.51846950 |
| 111 | negative regulation of lipase activity (GO:0060192) | 2.48655248 |
| 112 | lipoprotein metabolic process (GO:0042157) | 2.48293092 |
| 113 | sterol homeostasis (GO:0055092) | 2.47819486 |
| 114 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.47633669 |
| 115 | cholesterol homeostasis (GO:0042632) | 2.47538787 |
| 116 | regulation of amino acid transport (GO:0051955) | 2.47298977 |
| 117 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.47116371 |
| 118 | neutrophil activation involved in immune response (GO:0002283) | 2.46525371 |
| 119 | amino-acid betaine metabolic process (GO:0006577) | 2.46280134 |
| 120 | cellular response to growth hormone stimulus (GO:0071378) | 2.45027034 |
| 121 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.44528370 |
| 122 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.44375553 |
| 123 | negative regulation of gluconeogenesis (GO:0045721) | 2.43735225 |
| 124 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.43687110 |
| 125 | embryonic process involved in female pregnancy (GO:0060136) | 2.43439074 |
| 126 | cellular biogenic amine catabolic process (GO:0042402) | 2.43366413 |
| 127 | amine catabolic process (GO:0009310) | 2.43366413 |
| 128 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.43074369 |
| 129 | protein activation cascade (GO:0072376) | 2.42836790 |
| 130 | mature B cell differentiation (GO:0002335) | 2.42783879 |
| 131 | positive regulation of interferon-alpha production (GO:0032727) | 2.42694310 |
| 132 | complement activation (GO:0006956) | 2.42030009 |
| 133 | regulation of interferon-alpha production (GO:0032647) | 2.40144540 |
| 134 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.40010737 |
| 135 | morphogenesis of an epithelial sheet (GO:0002011) | 2.39687121 |
| 136 | protein-lipid complex subunit organization (GO:0071825) | 2.39665720 |
| 137 | plasma lipoprotein particle organization (GO:0071827) | 2.39062692 |
| 138 | positive regulation of p38MAPK cascade (GO:1900745) | 2.37717030 |
| 139 | negative regulation of hemostasis (GO:1900047) | 2.37094639 |
| 140 | negative regulation of blood coagulation (GO:0030195) | 2.37094639 |
| 141 | regulation of plasminogen activation (GO:0010755) | 2.37028361 |
| 142 | skin morphogenesis (GO:0043589) | 2.36940641 |
| 143 | ethanol oxidation (GO:0006069) | 2.36832864 |
| 144 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.35911099 |
| 145 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.35911099 |
| 146 | bile acid and bile salt transport (GO:0015721) | 2.34157143 |
| 147 | valine metabolic process (GO:0006573) | 2.33683639 |
| 148 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.32859124 |
| 149 | atrial septum morphogenesis (GO:0060413) | 2.32491049 |
| 150 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.31585655 |
| 151 | keratinocyte differentiation (GO:0030216) | 2.31003806 |
| 152 | epithelial cell fate commitment (GO:0072148) | 2.30642045 |
| 153 | regulation of protein polyubiquitination (GO:1902914) | 2.29864801 |
| 154 | mRNA transcription (GO:0009299) | 2.29084334 |
| 155 | establishment of skin barrier (GO:0061436) | 2.29032802 |
| 156 | definitive hemopoiesis (GO:0060216) | 2.28885690 |
| 157 | muscle cell fate commitment (GO:0042693) | 2.28391889 |
| 158 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.27034612 |
| 159 | regulation of transforming growth factor beta production (GO:0071634) | 2.25770163 |
| 160 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.22599594 |
| 161 | interkinetic nuclear migration (GO:0022027) | 2.21194880 |
| 162 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.20941965 |
| 163 | pharyngeal system development (GO:0060037) | 2.18305068 |
| 164 | negative regulation of anoikis (GO:2000811) | 2.18207816 |
| 165 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.14565602 |
| 166 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.14315653 |
| 167 | negative regulation of cardiac muscle tissue development (GO:0055026) | 2.13276123 |
| 168 | mature B cell differentiation involved in immune response (GO:0002313) | 2.13226254 |
| 169 | regulation of fibroblast apoptotic process (GO:2000269) | 2.12575667 |
| 170 | regulation of smooth muscle cell differentiation (GO:0051150) | 2.12172549 |
| 171 | histone H3-K9 demethylation (GO:0033169) | 2.11862627 |
| 172 | negative regulation of activin receptor signaling pathway (GO:0032926) | 2.11211352 |
| 173 | regulation of vitamin metabolic process (GO:0030656) | 2.10393029 |
| 174 | regulation of keratinocyte differentiation (GO:0045616) | 2.08545754 |
| 175 | regulation of neuron projection regeneration (GO:0070570) | 2.08369836 |
| 176 | regulation of axon regeneration (GO:0048679) | 2.08369836 |
| 177 | Notch signaling involved in heart development (GO:0061314) | 2.06739452 |
| 178 | negative regulation of actin filament depolymerization (GO:0030835) | 2.06729903 |
| 179 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.06448342 |
| 180 | wound healing, spreading of epidermal cells (GO:0035313) | 2.05849904 |
| 181 | mitotic sister chromatid cohesion (GO:0007064) | 2.04631026 |
| 182 | pore complex assembly (GO:0046931) | 2.04256529 |
| 183 | glycoprotein catabolic process (GO:0006516) | 2.03424855 |
| 184 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.01936353 |
| 185 | cellular response to osmotic stress (GO:0071470) | 2.01744448 |
| 186 | polyol transport (GO:0015791) | 2.01264365 |
| 187 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.00037922 |
| 188 | gastrulation with mouth forming second (GO:0001702) | 1.99739895 |
| 189 | negative regulation of exocytosis (GO:0045920) | 1.99018051 |
| 190 | N-glycan processing (GO:0006491) | 1.98116507 |
| 191 | regulation of water loss via skin (GO:0033561) | 1.97240385 |
| 192 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 1.95764388 |
| 193 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787) | 1.95570450 |
| 194 | long-term synaptic potentiation (GO:0060291) | 1.95470519 |
| 195 | negative regulation of heart growth (GO:0061117) | 1.94039145 |
| 196 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 1.94039145 |
| 197 | negative regulation of fatty acid transport (GO:2000192) | 1.93829541 |
| 198 | columnar/cuboidal epithelial cell development (GO:0002066) | 1.93049089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.71970888 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.28716596 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.17204845 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.90469896 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.64144620 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.63743002 |
| 7 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.56725637 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.34849410 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.81540080 |
| 10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.62851446 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.55180227 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.54250393 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.45404232 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.39031427 |
| 15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.35856744 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.35690114 |
| 17 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.33397013 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.29635936 |
| 19 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.28311569 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.20065127 |
| 21 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.19536744 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.16558501 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.14325087 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.07877065 |
| 25 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.06496251 |
| 26 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 2.04256554 |
| 27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.04230369 |
| 28 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.01991882 |
| 29 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.89406978 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.87574351 |
| 31 | GATA1_22025678_ChIP-Seq_K562_Human | 1.85656593 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.84765894 |
| 33 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.84507697 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.82802568 |
| 35 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.82063825 |
| 36 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.78673248 |
| 37 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.74996513 |
| 38 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.71403908 |
| 39 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.70504714 |
| 40 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.69966739 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.59759875 |
| 42 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.59270356 |
| 43 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.57032530 |
| 44 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.54587704 |
| 45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.53912649 |
| 46 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.51820164 |
| 47 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.50903753 |
| 48 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.49020958 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.48483322 |
| 50 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.47281500 |
| 51 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47055010 |
| 52 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46757473 |
| 53 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.44910806 |
| 54 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.44715222 |
| 55 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.44446443 |
| 56 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.44205090 |
| 57 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.43994996 |
| 58 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.43866362 |
| 59 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.37827902 |
| 60 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.34680931 |
| 61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.34327749 |
| 62 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32249388 |
| 63 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32078735 |
| 64 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.31702699 |
| 65 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.30995235 |
| 66 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.30995235 |
| 67 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.30824087 |
| 68 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.29656353 |
| 69 | CJUN_26792858_Chip-Seq_BT549_Human | 1.28628332 |
| 70 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.28083740 |
| 71 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.27750564 |
| 72 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.27671035 |
| 73 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.27630487 |
| 74 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.26770263 |
| 75 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.25957137 |
| 76 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24438242 |
| 77 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23921879 |
| 78 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.23917397 |
| 79 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.23917397 |
| 80 | MYB_26560356_Chip-Seq_TH2_Human | 1.23801037 |
| 81 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23596155 |
| 82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.21533637 |
| 83 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.21434694 |
| 84 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.21324279 |
| 85 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.20996025 |
| 86 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.20981042 |
| 87 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19214937 |
| 88 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.17010812 |
| 89 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.16957036 |
| 90 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.16360696 |
| 91 | FUS_26573619_Chip-Seq_HEK293_Human | 1.15715366 |
| 92 | MAF_26560356_Chip-Seq_TH1_Human | 1.14835000 |
| 93 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13788871 |
| 94 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.13472225 |
| 95 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.13132373 |
| 96 | MYB_26560356_Chip-Seq_TH1_Human | 1.12617270 |
| 97 | * TP53_16413492_ChIP-PET_HCT116_Human | 1.12561775 |
| 98 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.11680296 |
| 99 | EWS_26573619_Chip-Seq_HEK293_Human | 1.11534516 |
| 100 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.10667748 |
| 101 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.08857409 |
| 102 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.08182125 |
| 103 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06807456 |
| 104 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.06648042 |
| 105 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05796684 |
| 106 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.05448068 |
| 107 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04862469 |
| 108 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04087989 |
| 109 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.03959927 |
| 110 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.03687170 |
| 111 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.03570553 |
| 112 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.03537193 |
| 113 | P300_19829295_ChIP-Seq_ESCs_Human | 1.02230995 |
| 114 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02107843 |
| 115 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.01855658 |
| 116 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01854332 |
| 117 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.01149773 |
| 118 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.01073524 |
| 119 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.00880205 |
| 120 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.00431209 |
| 121 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97657902 |
| 122 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.97620353 |
| 123 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97618793 |
| 124 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.97189970 |
| 125 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.96972316 |
| 126 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.96633915 |
| 127 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.96222741 |
| 128 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95929651 |
| 129 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95837174 |
| 130 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94954210 |
| 131 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94292504 |
| 132 | GATA2_19941826_ChIP-Seq_K562_Human | 0.94035250 |
| 133 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.93094056 |
| 134 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92965722 |
| 135 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.92444627 |
| 136 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.91426063 |
| 137 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.91255448 |
| 138 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90315262 |
| 139 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90260147 |
| 140 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90088647 |
| 141 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.89963970 |
| 142 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.89555563 |
| 143 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89035947 |
| 144 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.88677934 |
| 145 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88569370 |
| 146 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.88541564 |
| 147 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.87511238 |
| 148 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86956598 |
| 149 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.86302299 |
| 150 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.86242574 |
| 151 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.86045828 |
| 152 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.85472317 |
| 153 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.83621708 |
| 154 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.81486909 |
| 155 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.81303573 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.09020296 |
| 2 | MP0005360_urolithiasis | 3.84657841 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.05081653 |
| 4 | MP0005365_abnormal_bile_salt | 2.95282677 |
| 5 | MP0002009_preneoplasia | 2.79997774 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 2.49875310 |
| 7 | MP0002396_abnormal_hematopoietic_system | 2.48144844 |
| 8 | MP0006054_spinal_hemorrhage | 2.30836318 |
| 9 | MP0008961_abnormal_basal_metabolism | 2.27654981 |
| 10 | MP0004808_abnormal_hematopoietic_stem | 2.26840110 |
| 11 | MP0003252_abnormal_bile_duct | 2.22627965 |
| 12 | MP0005409_darkened_coat_color | 2.22213774 |
| 13 | MP0003436_decreased_susceptibility_to | 2.21972786 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.20472177 |
| 15 | MP0008004_abnormal_stomach_pH | 2.17690938 |
| 16 | MP0003724_increased_susceptibility_to | 2.17494740 |
| 17 | MP0009840_abnormal_foam_cell | 2.12419913 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.11897675 |
| 19 | MP0003303_peritoneal_inflammation | 2.10325266 |
| 20 | MP0008057_abnormal_DNA_replication | 2.06847402 |
| 21 | MP0003828_pulmonary_edema | 2.05106225 |
| 22 | MP0001835_abnormal_antigen_presentation | 2.01667130 |
| 23 | MP0003705_abnormal_hypodermis_morpholog | 1.99070825 |
| 24 | MP0005083_abnormal_biliary_tract | 1.94982905 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.90773636 |
| 26 | MP0010329_abnormal_lipoprotein_level | 1.90241646 |
| 27 | MP0000579_abnormal_nail_morphology | 1.83532860 |
| 28 | MP0009785_altered_susceptibility_to | 1.82393601 |
| 29 | MP0004947_skin_inflammation | 1.79142763 |
| 30 | MP0003195_calcinosis | 1.72603538 |
| 31 | MP0001666_abnormal_nutrient_absorption | 1.69678659 |
| 32 | MP0008438_abnormal_cutaneous_collagen | 1.64233677 |
| 33 | MP0000685_abnormal_immune_system | 1.62149130 |
| 34 | MP0002419_abnormal_innate_immunity | 1.61873361 |
| 35 | MP0005387_immune_system_phenotype | 1.61400420 |
| 36 | MP0001790_abnormal_immune_system | 1.61400420 |
| 37 | MP0002254_reproductive_system_inflammat | 1.60875748 |
| 38 | MP0004215_abnormal_myocardial_fiber | 1.60847143 |
| 39 | MP0005000_abnormal_immune_tolerance | 1.57257338 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.54166180 |
| 41 | MP0010234_abnormal_vibrissa_follicle | 1.52757430 |
| 42 | MP0001800_abnormal_humoral_immune | 1.52092775 |
| 43 | MP0006082_CNS_inflammation | 1.51949237 |
| 44 | MP0009764_decreased_sensitivity_to | 1.51861534 |
| 45 | MP0004084_abnormal_cardiac_muscle | 1.51562964 |
| 46 | MP0005025_abnormal_response_to | 1.50837398 |
| 47 | MP0000609_abnormal_liver_physiology | 1.50681698 |
| 48 | MP0005076_abnormal_cell_differentiation | 1.49413286 |
| 49 | MP0005451_abnormal_body_composition | 1.47374738 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.47305390 |
| 51 | MP0004883_abnormal_blood_vessel | 1.44525250 |
| 52 | MP0001915_intracranial_hemorrhage | 1.42816112 |
| 53 | MP0004272_abnormal_basement_membrane | 1.42475179 |
| 54 | MP0002166_altered_tumor_susceptibility | 1.41662826 |
| 55 | MP0002452_abnormal_antigen_presenting | 1.39019149 |
| 56 | MP0002933_joint_inflammation | 1.38250913 |
| 57 | MP0002148_abnormal_hypersensitivity_rea | 1.37046146 |
| 58 | MP0003941_abnormal_skin_development | 1.35970945 |
| 59 | MP0001853_heart_inflammation | 1.34798387 |
| 60 | MP0000569_abnormal_digit_pigmentation | 1.34728603 |
| 61 | * MP0003453_abnormal_keratinocyte_physiol | 1.33344833 |
| 62 | MP0002723_abnormal_immune_serum | 1.33178738 |
| 63 | MP0005671_abnormal_response_to | 1.29552347 |
| 64 | MP0010155_abnormal_intestine_physiology | 1.29041661 |
| 65 | MP0008469_abnormal_protein_level | 1.28894859 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.27612201 |
| 67 | MP0003806_abnormal_nucleotide_metabolis | 1.27505400 |
| 68 | MP0005275_abnormal_skin_tensile | 1.25706824 |
| 69 | MP0000767_abnormal_smooth_muscle | 1.25384809 |
| 70 | MP0002006_tumorigenesis | 1.24769381 |
| 71 | MP0002060_abnormal_skin_morphology | 1.23427167 |
| 72 | MP0005332_abnormal_amino_acid | 1.22587750 |
| 73 | MP0004510_myositis | 1.22009160 |
| 74 | MP0005503_abnormal_tendon_morphology | 1.21608326 |
| 75 | MP0001177_atelectasis | 1.21543345 |
| 76 | MP0002133_abnormal_respiratory_system | 1.21356908 |
| 77 | MP0005388_respiratory_system_phenotype | 1.21356908 |
| 78 | MP0002118_abnormal_lipid_homeostasis | 1.20803439 |
| 79 | MP0003690_abnormal_glial_cell | 1.19611832 |
| 80 | MP0000762_abnormal_tongue_morphology | 1.19599470 |
| 81 | MP0009384_cardiac_valve_regurgitation | 1.18327791 |
| 82 | MP0003566_abnormal_cell_adhesion | 1.17871322 |
| 83 | MP0010352_gastrointestinal_tract_polyps | 1.16292873 |
| 84 | MP0000465_gastrointestinal_hemorrhage | 1.15578080 |
| 85 | MP0010368_abnormal_lymphatic_system | 1.15474313 |
| 86 | MP0002234_abnormal_pharynx_morphology | 1.14822684 |
| 87 | MP0009763_increased_sensitivity_to | 1.13803662 |
| 88 | MP0005023_abnormal_wound_healing | 1.13646451 |
| 89 | MP0005666_abnormal_adipose_tissue | 1.13385090 |
| 90 | MP0001819_abnormal_immune_cell | 1.12812407 |
| 91 | MP0002420_abnormal_adaptive_immunity | 1.12637559 |
| 92 | MP0004484_altered_response_of | 1.11757318 |
| 93 | MP0003935_abnormal_craniofacial_develop | 1.10133340 |
| 94 | MP0001873_stomach_inflammation | 1.09916997 |
| 95 | MP0005408_hypopigmentation | 1.09718415 |
| 96 | MP0002896_abnormal_bone_mineralization | 1.09407936 |
| 97 | MP0004019_abnormal_vitamin_homeostasis | 1.08272825 |
| 98 | MP0005595_abnormal_vascular_smooth | 1.07322062 |
| 99 | MP0000432_abnormal_head_morphology | 1.06640429 |
| 100 | MP0005058_abnormal_lysosome_morphology | 1.06449814 |
| 101 | MP0002405_respiratory_system_inflammati | 1.05326463 |
| 102 | MP0003115_abnormal_respiratory_system | 1.04120229 |
| 103 | MP0002998_abnormal_bone_remodeling | 1.02970971 |
| 104 | MP0005319_abnormal_enzyme/_coenzyme | 1.02716047 |
| 105 | MP0000604_amyloidosis | 1.01789114 |
| 106 | MP0001851_eye_inflammation | 1.01105238 |
| 107 | MP0000428_abnormal_craniofacial_morphol | 0.99934538 |
| 108 | MP0010678_abnormal_skin_adnexa | 0.99111424 |
| 109 | MP0002796_impaired_skin_barrier | 0.99080037 |
| 110 | MP0002233_abnormal_nose_morphology | 0.99014678 |
| 111 | MP0003868_abnormal_feces_composition | 0.98638812 |
| 112 | MP0003448_altered_tumor_morphology | 0.98157110 |
| 113 | MP0005167_abnormal_blood-brain_barrier | 0.96546619 |
| 114 | MP0009697_abnormal_copulation | 0.95510180 |
| 115 | MP0010630_abnormal_cardiac_muscle | 0.95030616 |
| 116 | MP0005501_abnormal_skin_physiology | 0.93472592 |
| 117 | MP0000858_altered_metastatic_potential | 0.93182629 |
| 118 | MP0000383_abnormal_hair_follicle | 0.92776326 |
| 119 | * MP0001216_abnormal_epidermal_layer | 0.92204334 |
| 120 | MP0001879_abnormal_lymphatic_vessel | 0.91962906 |
| 121 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.91806681 |
| 122 | MP0000598_abnormal_liver_morphology | 0.90882423 |
| 123 | MP0001243_abnormal_dermal_layer | 0.90168948 |
| 124 | MP0005166_decreased_susceptibility_to | 0.88827642 |
| 125 | MP0003763_abnormal_thymus_physiology | 0.88596741 |
| 126 | MP0002877_abnormal_melanocyte_morpholog | 0.88543044 |
| 127 | MP0000013_abnormal_adipose_tissue | 0.88171001 |
| 128 | MP0003075_altered_response_to | 0.87271861 |
| 129 | MP0003656_abnormal_erythrocyte_physiolo | 0.86797795 |
| 130 | MP0009643_abnormal_urine_homeostasis | 0.85786802 |
| 131 | MP0010771_integument_phenotype | 0.85559637 |
| 132 | MP0004185_abnormal_adipocyte_glucose | 0.85187461 |
| 133 | MP0003890_abnormal_embryonic-extraembry | 0.84165096 |
| 134 | MP0000343_altered_response_to | 0.84137752 |
| 135 | MP0000249_abnormal_blood_vessel | 0.83872624 |
| 136 | MP0001849_ear_inflammation | 0.83839348 |
| 137 | MP0003091_abnormal_cell_migration | 0.83589824 |
| 138 | MP0005164_abnormal_response_to | 0.82936890 |
| 139 | MP0006138_congestive_heart_failure | 0.82749442 |
| 140 | MP0003045_fibrosis | 0.82710863 |
| 141 | MP0003186_abnormal_redox_activity | 0.82705552 |
| 142 | MP0004264_abnormal_extraembryonic_tissu | 0.81718132 |
| 143 | MP0001881_abnormal_mammary_gland | 0.80790999 |
| 144 | MP0000716_abnormal_immune_system | 0.80359927 |
| 145 | MP0002925_abnormal_cardiovascular_devel | 0.79701705 |
| 146 | MP0002086_abnormal_extraembryonic_tissu | 0.79651255 |
| 147 | MP0004782_abnormal_surfactant_physiolog | 0.78954357 |
| 148 | MP0001784_abnormal_fluid_regulation | 0.78744285 |
| 149 | * MP0001191_abnormal_skin_condition | 0.76436313 |
| 150 | MP0003279_aneurysm | 0.76083697 |
| 151 | MP0003755_abnormal_palate_morphology | 0.74680410 |
| 152 | MP0010307_abnormal_tumor_latency | 0.74570010 |
| 153 | MP0004036_abnormal_muscle_relaxation | 0.73853733 |
| 154 | MP0001188_hyperpigmentation | 0.71722834 |
| 155 | MP0001614_abnormal_blood_vessel | 0.69091614 |
| 156 | MP0000566_synostosis | 0.68951254 |
| 157 | * MP0003634_abnormal_glial_cell | 0.68726277 |
| 158 | MP0002092_abnormal_eye_morphology | 0.68598698 |
| 159 | MP0002971_abnormal_brown_adipose | 0.67585515 |
| 160 | MP0005508_abnormal_skeleton_morphology | 0.67270144 |
| 161 | MP0000678_abnormal_parathyroid_gland | 0.66541368 |
| 162 | MP0003183_abnormal_peptide_metabolism | 0.66197256 |
| 163 | MP0002822_catalepsy | 0.65913425 |
| 164 | MP0002128_abnormal_blood_circulation | 0.65623841 |
| 165 | MP0002108_abnormal_muscle_morphology | 0.65215583 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.04973115 |
| 2 | Xanthomatosis (HP:0000991) | 4.42184218 |
| 3 | Myocardial infarction (HP:0001658) | 4.28063965 |
| 4 | Vertebral arch anomaly (HP:0008438) | 4.18411840 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.16675608 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.97719777 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 3.85698345 |
| 8 | Abnormality of the common coagulation pathway (HP:0010990) | 3.82635549 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 3.81399109 |
| 10 | Papillary thyroid carcinoma (HP:0002895) | 3.59846305 |
| 11 | Joint hemorrhage (HP:0005261) | 3.56159320 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.55637260 |
| 13 | Eczematoid dermatitis (HP:0000976) | 3.54393735 |
| 14 | Complement deficiency (HP:0004431) | 3.49387923 |
| 15 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.47682888 |
| 16 | Arterial tortuosity (HP:0005116) | 3.27866900 |
| 17 | Epidermoid cyst (HP:0200040) | 3.09965847 |
| 18 | Hypobetalipoproteinemia (HP:0003563) | 3.05329352 |
| 19 | Vascular tortuosity (HP:0004948) | 3.05105693 |
| 20 | Right ventricular cardiomyopathy (HP:0011663) | 3.03627300 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 2.98015143 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.95552478 |
| 23 | Gingival bleeding (HP:0000225) | 2.93626342 |
| 24 | Peritonitis (HP:0002586) | 2.88095554 |
| 25 | Recurrent bacterial skin infections (HP:0005406) | 2.84810173 |
| 26 | Abnormality of complement system (HP:0005339) | 2.82775374 |
| 27 | Hypolipoproteinemia (HP:0010981) | 2.81839628 |
| 28 | Ankyloglossia (HP:0010296) | 2.78879657 |
| 29 | Hematochezia (HP:0002573) | 2.75615860 |
| 30 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.72788705 |
| 31 | Pulmonary embolism (HP:0002204) | 2.71822545 |
| 32 | Systemic lupus erythematosus (HP:0002725) | 2.66665329 |
| 33 | Orchitis (HP:0100796) | 2.66350660 |
| 34 | Fat malabsorption (HP:0002630) | 2.61891169 |
| 35 | Myositis (HP:0100614) | 2.60487470 |
| 36 | Atrophic scars (HP:0001075) | 2.59604787 |
| 37 | Esophageal varix (HP:0002040) | 2.59111826 |
| 38 | Vascular calcification (HP:0004934) | 2.59055741 |
| 39 | Osteolytic defects of the hand bones (HP:0009699) | 2.58725853 |
| 40 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.58725853 |
| 41 | Abnormality of the intrinsic pathway (HP:0010989) | 2.56243846 |
| 42 | Recurrent abscess formation (HP:0002722) | 2.55078141 |
| 43 | Cardiovascular calcification (HP:0011915) | 2.55010114 |
| 44 | Hypercholesterolemia (HP:0003124) | 2.54362443 |
| 45 | Curly hair (HP:0002212) | 2.51927926 |
| 46 | Flat acetabular roof (HP:0003180) | 2.50912862 |
| 47 | Hepatocellular carcinoma (HP:0001402) | 2.47381930 |
| 48 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.44883890 |
| 49 | Abnormal platelet volume (HP:0011876) | 2.44764387 |
| 50 | Absent frontal sinuses (HP:0002688) | 2.44562820 |
| 51 | Increased mean platelet volume (HP:0011877) | 2.41326030 |
| 52 | Arterial thrombosis (HP:0004420) | 2.40240787 |
| 53 | Mitral stenosis (HP:0001718) | 2.40181782 |
| 54 | Spontaneous hematomas (HP:0007420) | 2.39387888 |
| 55 | Abnormality of the renal collecting system (HP:0004742) | 2.37433393 |
| 56 | Thrombophlebitis (HP:0004418) | 2.36693062 |
| 57 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.36487429 |
| 58 | Abnormality of macrophages (HP:0004311) | 2.35884231 |
| 59 | Optic neuritis (HP:0100653) | 2.35670769 |
| 60 | Retrobulbar optic neuritis (HP:0100654) | 2.35670769 |
| 61 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.33400077 |
| 62 | Nephritis (HP:0000123) | 2.32587125 |
| 63 | Abnormality of methionine metabolism (HP:0010901) | 2.32536204 |
| 64 | Lip pit (HP:0100267) | 2.27565167 |
| 65 | Absent/shortened dynein arms (HP:0200106) | 2.27406346 |
| 66 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.27406346 |
| 67 | Spinal cord lesions (HP:0100561) | 2.27393410 |
| 68 | Syringomyelia (HP:0003396) | 2.27393410 |
| 69 | Amyloidosis (HP:0011034) | 2.26639874 |
| 70 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.26533697 |
| 71 | Vertebral hypoplasia (HP:0008417) | 2.26533697 |
| 72 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.25131321 |
| 73 | Interstitial pulmonary disease (HP:0006530) | 2.24230164 |
| 74 | Cubitus valgus (HP:0002967) | 2.23416725 |
| 75 | Spontaneous abortion (HP:0005268) | 2.23066186 |
| 76 | Menorrhagia (HP:0000132) | 2.22073255 |
| 77 | Aplasia cutis congenita (HP:0001057) | 2.20154448 |
| 78 | Glomerulonephritis (HP:0000099) | 2.18771684 |
| 79 | Steatorrhea (HP:0002570) | 2.18425731 |
| 80 | Cerebral aneurysm (HP:0004944) | 2.17311985 |
| 81 | Thick nail (HP:0001805) | 2.16671184 |
| 82 | Vasculitis (HP:0002633) | 2.16216038 |
| 83 | Thickened helices (HP:0000391) | 2.15733444 |
| 84 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.13147781 |
| 85 | Aplasia of the phalanges of the hand (HP:0009802) | 2.13147781 |
| 86 | Aplasia involving bones of the extremities (HP:0009825) | 2.13147781 |
| 87 | Recurrent skin infections (HP:0001581) | 2.11148008 |
| 88 | Epistaxis (HP:0000421) | 2.09310222 |
| 89 | Gastrointestinal infarctions (HP:0005244) | 2.08248061 |
| 90 | Dilatation of the ascending aorta (HP:0005111) | 2.08042963 |
| 91 | Subacute progressive viral hepatitis (HP:0006572) | 2.07424830 |
| 92 | Widely spaced teeth (HP:0000687) | 2.05069786 |
| 93 | Abnormality of chromosome segregation (HP:0002916) | 2.04842915 |
| 94 | Abnormality of iron homeostasis (HP:0011031) | 2.03664070 |
| 95 | Hyperammonemia (HP:0001987) | 2.03486917 |
| 96 | Abnormality of the lumbar spine (HP:0100712) | 2.02822611 |
| 97 | Conjugated hyperbilirubinemia (HP:0002908) | 2.01179583 |
| 98 | Abnormality of the axillary hair (HP:0100134) | 2.00926802 |
| 99 | Abnormality of secondary sexual hair (HP:0009888) | 2.00926802 |
| 100 | Abnormal foot bone ossification (HP:0010675) | 2.00861340 |
| 101 | Menstrual irregularities (HP:0000858) | 2.00138150 |
| 102 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.99383952 |
| 103 | Thyroid carcinoma (HP:0002890) | 1.98279869 |
| 104 | Abnormality of oral frenula (HP:0000190) | 1.97523891 |
| 105 | Selective tooth agenesis (HP:0001592) | 1.96466126 |
| 106 | Plantar hyperkeratosis (HP:0007556) | 1.96253468 |
| 107 | Vacuolated lymphocytes (HP:0001922) | 1.96080999 |
| 108 | Palmar hyperkeratosis (HP:0010765) | 1.95216203 |
| 109 | Disinhibition (HP:0000734) | 1.94057629 |
| 110 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.93886002 |
| 111 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.93853353 |
| 112 | Large earlobe (HP:0009748) | 1.92012132 |
| 113 | Deep philtrum (HP:0002002) | 1.91665024 |
| 114 | Aortic aneurysm (HP:0004942) | 1.89687631 |
| 115 | Abnormality of proline metabolism (HP:0010907) | 1.89652021 |
| 116 | Hydroxyprolinuria (HP:0003080) | 1.89652021 |
| 117 | Xerostomia (HP:0000217) | 1.89228601 |
| 118 | Periodontitis (HP:0000704) | 1.89108382 |
| 119 | Axonal loss (HP:0003447) | 1.88535779 |
| 120 | Bladder carcinoma (HP:0002862) | 1.88306600 |
| 121 | Bladder neoplasm (HP:0009725) | 1.88306600 |
| 122 | Palmoplantar hyperkeratosis (HP:0000972) | 1.87167544 |
| 123 | Keratoconjunctivitis sicca (HP:0001097) | 1.86723479 |
| 124 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85307736 |
| 125 | Pustule (HP:0200039) | 1.85088356 |
| 126 | Abnormal tarsal ossification (HP:0008369) | 1.84868795 |
| 127 | Hypoplastic labia majora (HP:0000059) | 1.84563525 |
| 128 | Hypoglycemic coma (HP:0001325) | 1.84056293 |
| 129 | Recurrent fungal infections (HP:0002841) | 1.84042159 |
| 130 | Hemorrhage of the eye (HP:0011885) | 1.83965499 |
| 131 | Stomatitis (HP:0010280) | 1.83171769 |
| 132 | Recurrent viral infections (HP:0004429) | 1.82306315 |
| 133 | Purpura (HP:0000979) | 1.81521896 |
| 134 | Mitral valve prolapse (HP:0001634) | 1.81240987 |
| 135 | Ectopia lentis (HP:0001083) | 1.81200669 |
| 136 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.81071899 |
| 137 | Increased serum ferritin (HP:0003281) | 1.80203079 |
| 138 | Gangrene (HP:0100758) | 1.80152073 |
| 139 | Protuberant abdomen (HP:0001538) | 1.79480158 |
| 140 | Milia (HP:0001056) | 1.79264737 |
| 141 | Short middle phalanx of the 5th finger (HP:0004220) | 1.79197243 |
| 142 | Autoimmune thrombocytopenia (HP:0001973) | 1.78724818 |
| 143 | Striae distensae (HP:0001065) | 1.78599288 |
| 144 | Skin nodule (HP:0200036) | 1.78560110 |
| 145 | Pancreatitis (HP:0001733) | 1.77866671 |
| 146 | Tetraparesis (HP:0002273) | 1.76838009 |
| 147 | Colitis (HP:0002583) | 1.75579542 |
| 148 | Mediastinal lymphadenopathy (HP:0100721) | 1.73860989 |
| 149 | Pulmonary infiltrates (HP:0002113) | 1.73549108 |
| 150 | Submucous cleft hard palate (HP:0000176) | 1.73363325 |
| 151 | Asymmetry of the thorax (HP:0001555) | 1.73294839 |
| 152 | Hypertriglyceridemia (HP:0002155) | 1.73291320 |
| 153 | Thoracolumbar scoliosis (HP:0002944) | 1.73012493 |
| 154 | Inappropriate behavior (HP:0000719) | 1.71247244 |
| 155 | Onycholysis (HP:0001806) | 1.71202767 |
| 156 | Urticaria (HP:0001025) | 1.70837632 |
| 157 | Abnormality of the labia majora (HP:0012881) | 1.70687166 |
| 158 | Abnormality of nail color (HP:0100643) | 1.70653711 |
| 159 | Hypotrichosis (HP:0001006) | 1.70625286 |
| 160 | Aortic dissection (HP:0002647) | 1.70415244 |
| 161 | Abnormality of incisor morphology (HP:0011063) | 1.70313203 |
| 162 | Fused cervical vertebrae (HP:0002949) | 1.69379145 |
| 163 | Long nose (HP:0003189) | 1.68337785 |
| 164 | Abnormality of the nasolacrimal system (HP:0000614) | 1.64661320 |
| 165 | Fair hair (HP:0002286) | 1.63655124 |
| 166 | Sparse scalp hair (HP:0002209) | 1.63558989 |
| 167 | Mixed hearing impairment (HP:0000410) | 1.62989385 |
| 168 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.62881967 |
| 169 | Cranial hyperostosis (HP:0004437) | 1.61736233 |
| 170 | Atrioventricular block (HP:0001678) | 1.60995284 |
| 171 | Lower limb hyperreflexia (HP:0002395) | 1.60658539 |
| 172 | Abnormality of the salivary glands (HP:0010286) | 1.60564047 |
| 173 | Cystic hygroma (HP:0000476) | 1.59949346 |
| 174 | Scanning speech (HP:0002168) | 1.59053950 |
| 175 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.58929609 |
| 176 | Megalencephaly (HP:0001355) | 1.58904424 |
| 177 | Ridged nail (HP:0001807) | 1.58710832 |
| 178 | Fragile skin (HP:0001030) | 1.58646185 |
| 179 | Overgrowth (HP:0001548) | 1.58090231 |
| 180 | Aneurysm (HP:0002617) | 1.56994510 |
| 181 | Heterotopia (HP:0002282) | 1.56173050 |
| 182 | Broad palm (HP:0001169) | 1.54292678 |
| 183 | Uterine leiomyosarcoma (HP:0002891) | 1.53859516 |
| 184 | Leiomyosarcoma (HP:0100243) | 1.53859516 |
| 185 | Abnormality of the lacrimal duct (HP:0011481) | 1.52619583 |
| 186 | Craniofacial hyperostosis (HP:0004493) | 1.52514157 |
| 187 | Abnormal cortical bone morphology (HP:0003103) | 1.52212379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EIF2AK3 | 4.62270092 |
| 2 | MAP3K14 | 3.23042029 |
| 3 | FGFR4 | 2.83717142 |
| 4 | LATS2 | 2.77178288 |
| 5 | TYK2 | 2.71018502 |
| 6 | STK38L | 2.66123180 |
| 7 | EPHB1 | 2.45205023 |
| 8 | TBK1 | 2.35532234 |
| 9 | MAP4K1 | 2.34336587 |
| 10 | EPHA3 | 2.21640143 |
| 11 | ERN1 | 2.15486314 |
| 12 | LATS1 | 2.15383273 |
| 13 | JAK1 | 2.14936646 |
| 14 | TAOK3 | 2.07310231 |
| 15 | MST1R | 2.03413217 |
| 16 | JAK3 | 2.01450180 |
| 17 | IKBKE | 1.99465643 |
| 18 | TXK | 1.90973163 |
| 19 | TRIB3 | 1.89474254 |
| 20 | FGFR3 | 1.85559215 |
| 21 | SIK1 | 1.73706779 |
| 22 | STK10 | 1.70010262 |
| 23 | RIPK1 | 1.68134480 |
| 24 | BRD4 | 1.67388658 |
| 25 | PKN2 | 1.61100944 |
| 26 | ITK | 1.60964355 |
| 27 | MAP3K3 | 1.56260721 |
| 28 | FRK | 1.52646747 |
| 29 | PTK6 | 1.51105892 |
| 30 | SGK2 | 1.45444500 |
| 31 | LRRK2 | 1.44782503 |
| 32 | TGFBR2 | 1.42690674 |
| 33 | FGFR2 | 1.42110543 |
| 34 | IKBKB | 1.39290057 |
| 35 | NEK9 | 1.39163734 |
| 36 | STK3 | 1.34626475 |
| 37 | CSK | 1.32205032 |
| 38 | CDK12 | 1.31488847 |
| 39 | IRAK3 | 1.29901887 |
| 40 | BMX | 1.29569191 |
| 41 | IRAK2 | 1.29423946 |
| 42 | DDR2 | 1.28921251 |
| 43 | TEC | 1.26097010 |
| 44 | IRAK4 | 1.25833336 |
| 45 | MST4 | 1.22572110 |
| 46 | AKT3 | 1.20018596 |
| 47 | TTN | 1.18987037 |
| 48 | YES1 | 1.17704259 |
| 49 | ERBB3 | 1.11783457 |
| 50 | BLK | 1.11308135 |
| 51 | MET | 1.11192969 |
| 52 | KIT | 1.10831450 |
| 53 | BMPR2 | 1.10528411 |
| 54 | TRPM7 | 1.10154404 |
| 55 | CHUK | 1.09515463 |
| 56 | MKNK1 | 1.09279122 |
| 57 | WNK1 | 1.07674553 |
| 58 | SGK3 | 1.07413317 |
| 59 | MAP3K6 | 1.07153245 |
| 60 | ZAP70 | 1.06834070 |
| 61 | PIM2 | 1.06725939 |
| 62 | JAK2 | 1.06527987 |
| 63 | RPS6KA4 | 1.06402797 |
| 64 | STK38 | 1.06223112 |
| 65 | CDK6 | 1.06202864 |
| 66 | MKNK2 | 1.03027944 |
| 67 | KSR2 | 1.01465647 |
| 68 | MAP3K13 | 1.00284374 |
| 69 | EIF2AK2 | 0.99786154 |
| 70 | STK24 | 0.99201484 |
| 71 | CAMK1D | 0.95687962 |
| 72 | MAP2K3 | 0.94909059 |
| 73 | BTK | 0.94535573 |
| 74 | BCKDK | 0.89723798 |
| 75 | NUAK1 | 0.87671001 |
| 76 | PIM1 | 0.87520155 |
| 77 | LCK | 0.86459611 |
| 78 | PRKCQ | 0.83968902 |
| 79 | ERBB4 | 0.83542392 |
| 80 | HCK | 0.83414594 |
| 81 | KSR1 | 0.82022775 |
| 82 | PRPF4B | 0.81496366 |
| 83 | CSF1R | 0.81299382 |
| 84 | IRAK1 | 0.78288617 |
| 85 | PNCK | 0.77494167 |
| 86 | PBK | 0.76252274 |
| 87 | SGK223 | 0.75698116 |
| 88 | SGK494 | 0.75698116 |
| 89 | PDGFRB | 0.73653770 |
| 90 | PIK3CA | 0.72397072 |
| 91 | RPS6KB1 | 0.71788858 |
| 92 | MOS | 0.71586543 |
| 93 | EEF2K | 0.71125180 |
| 94 | MAP3K10 | 0.70995964 |
| 95 | PIK3CG | 0.68483044 |
| 96 | MAPK11 | 0.67675562 |
| 97 | FGFR1 | 0.67189414 |
| 98 | BRSK2 | 0.66315022 |
| 99 | NLK | 0.66073051 |
| 100 | CDK3 | 0.65942786 |
| 101 | GSK3A | 0.64223212 |
| 102 | ABL1 | 0.64159298 |
| 103 | TIE1 | 0.63978889 |
| 104 | EGFR | 0.59606243 |
| 105 | KDR | 0.57499987 |
| 106 | SGK1 | 0.57092717 |
| 107 | MELK | 0.54905482 |
| 108 | SYK | 0.54386282 |
| 109 | RET | 0.53574966 |
| 110 | MATK | 0.53021806 |
| 111 | ACVR1B | 0.51674410 |
| 112 | CAMK1G | 0.51571286 |
| 113 | TYRO3 | 0.51294151 |
| 114 | ABL2 | 0.51211063 |
| 115 | MAPK4 | 0.50639832 |
| 116 | IGF1R | 0.50270162 |
| 117 | STK39 | 0.50159777 |
| 118 | MAPK10 | 0.50081791 |
| 119 | PRKAA2 | 0.49383532 |
| 120 | PRKG2 | 0.49252415 |
| 121 | DYRK1B | 0.48911624 |
| 122 | MAP3K7 | 0.48856179 |
| 123 | BCR | 0.48080597 |
| 124 | EPHA2 | 0.47245741 |
| 125 | MARK3 | 0.46795466 |
| 126 | PTK2 | 0.45304987 |
| 127 | LYN | 0.45043523 |
| 128 | DMPK | 0.44203596 |
| 129 | MAP3K4 | 0.43804044 |
| 130 | MAP3K2 | 0.43422920 |
| 131 | TGFBR1 | 0.43117382 |
| 132 | MAP3K1 | 0.42228443 |
| 133 | PRKCH | 0.41867694 |
| 134 | HIPK2 | 0.41745424 |
| 135 | MAPK7 | 0.40570669 |
| 136 | CASK | 0.40540352 |
| 137 | GRK6 | 0.40276956 |
| 138 | PKN1 | 0.40276486 |
| 139 | PAK2 | 0.39918212 |
| 140 | CDK9 | 0.39854252 |
| 141 | PDGFRA | 0.38318760 |
| 142 | RAF1 | 0.38037079 |
| 143 | FGR | 0.37286239 |
| 144 | INSR | 0.36949380 |
| 145 | EPHA4 | 0.36663706 |
| 146 | MAP2K4 | 0.35055093 |
| 147 | MTOR | 0.29491938 |
| 148 | MAPK12 | 0.28066049 |
| 149 | PRKCE | 0.27722308 |
| 150 | RPS6KB2 | 0.27219578 |
| 151 | MAPK15 | 0.24933570 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.36588358 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.11002194 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.77169110 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.74325919 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.71403924 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.38050872 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.34715459 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.24962297 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.82343019 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.78691549 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.73418167 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.70468004 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.62898339 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 1.61370422 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.61083854 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.59135513 |
| 17 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.58396164 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.52699161 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.49738574 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.46407566 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.43209845 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.41559893 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.40592318 |
| 24 | Adherens junction_Homo sapiens_hsa04520 | 1.36821886 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.36810000 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.34360630 |
| 27 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.32049506 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.31124746 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.28031146 |
| 30 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.27741273 |
| 31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.24476294 |
| 32 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.24308610 |
| 33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.22250727 |
| 34 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.20650924 |
| 35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.18131268 |
| 36 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.17422216 |
| 37 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.15108327 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.14876240 |
| 39 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.14157131 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.12968394 |
| 41 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.10158294 |
| 42 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.10021115 |
| 43 | Renin secretion_Homo sapiens_hsa04924 | 1.08157623 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 1.07613847 |
| 45 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.06279865 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.06013660 |
| 47 | Glioma_Homo sapiens_hsa05214 | 1.05106083 |
| 48 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.03585484 |
| 49 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.03225693 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 1.03009744 |
| 51 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.02484944 |
| 52 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00985025 |
| 53 | Long-term depression_Homo sapiens_hsa04730 | 1.00977066 |
| 54 | Measles_Homo sapiens_hsa05162 | 1.00081580 |
| 55 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.99443229 |
| 56 | Endometrial cancer_Homo sapiens_hsa05213 | 0.99373793 |
| 57 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.99263327 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97705626 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.96869594 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.96294139 |
| 61 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.95778767 |
| 62 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.94577817 |
| 63 | Colorectal cancer_Homo sapiens_hsa05210 | 0.94427625 |
| 64 | Gap junction_Homo sapiens_hsa04540 | 0.92893630 |
| 65 | Long-term potentiation_Homo sapiens_hsa04720 | 0.92388573 |
| 66 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.91856278 |
| 67 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.91805961 |
| 68 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90192707 |
| 69 | Legionellosis_Homo sapiens_hsa05134 | 0.90012734 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.89869007 |
| 71 | Prostate cancer_Homo sapiens_hsa05215 | 0.89199313 |
| 72 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.87994935 |
| 73 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.87813040 |
| 74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.87308031 |
| 75 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.87232403 |
| 76 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.85870956 |
| 77 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.85806912 |
| 78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.85419994 |
| 79 | Circadian rhythm_Homo sapiens_hsa04710 | 0.83949199 |
| 80 | Thyroid cancer_Homo sapiens_hsa05216 | 0.83401241 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82906280 |
| 82 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82431735 |
| 83 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.82402320 |
| 84 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.81587877 |
| 85 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.81319334 |
| 86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81179198 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | 0.80938123 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.80698932 |
| 89 | Allograft rejection_Homo sapiens_hsa05330 | 0.79762771 |
| 90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.78600060 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.78426429 |
| 92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.77192020 |
| 93 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.76147843 |
| 94 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.75946790 |
| 95 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.75257091 |
| 96 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.74746299 |
| 97 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.73981836 |
| 98 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.73890558 |
| 99 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.72417214 |
| 100 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.72187399 |
| 101 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.72069036 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72033506 |
| 103 | Hepatitis C_Homo sapiens_hsa05160 | 0.71494237 |
| 104 | Pathways in cancer_Homo sapiens_hsa05200 | 0.71212473 |
| 105 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71116616 |
| 106 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.70663669 |
| 107 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.70002967 |
| 108 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.69640741 |
| 109 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.69384713 |
| 110 | Tuberculosis_Homo sapiens_hsa05152 | 0.68896239 |
| 111 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68697096 |
| 112 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.67810235 |
| 113 | Melanoma_Homo sapiens_hsa05218 | 0.65082293 |
| 114 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.64403957 |
| 115 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.64211457 |
| 116 | Platelet activation_Homo sapiens_hsa04611 | 0.64009644 |
| 117 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63575287 |
| 118 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.63100149 |
| 119 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.62231367 |
| 120 | Bladder cancer_Homo sapiens_hsa05219 | 0.62221739 |
| 121 | Lysine degradation_Homo sapiens_hsa00310 | 0.62084441 |
| 122 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61875447 |
| 123 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.60861455 |
| 124 | Influenza A_Homo sapiens_hsa05164 | 0.60829472 |
| 125 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.60789765 |
| 126 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59902004 |
| 127 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59797290 |
| 128 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.58591318 |
| 129 | Insulin resistance_Homo sapiens_hsa04931 | 0.57832935 |
| 130 | Tight junction_Homo sapiens_hsa04530 | 0.57457793 |
| 131 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57088665 |
| 132 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.56867950 |
| 133 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.56643290 |
| 134 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55605215 |
| 135 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55492592 |
| 136 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55051029 |
| 137 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.54663608 |
| 138 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54625271 |
| 139 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54119950 |
| 140 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53657526 |
| 141 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.53138435 |
| 142 | Apoptosis_Homo sapiens_hsa04210 | 0.52232338 |
| 143 | Focal adhesion_Homo sapiens_hsa04510 | 0.50763384 |
| 144 | Salmonella infection_Homo sapiens_hsa05132 | 0.50504613 |
| 145 | Hepatitis B_Homo sapiens_hsa05161 | 0.50352484 |
| 146 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.49796180 |
| 147 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48570917 |
| 148 | Shigellosis_Homo sapiens_hsa05131 | 0.48257192 |
| 149 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48120929 |
| 150 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.47994278 |
| 151 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47227881 |
| 152 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46306035 |
| 153 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.45494827 |
| 154 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.45304927 |
| 155 | Asthma_Homo sapiens_hsa05310 | 0.43989734 |
| 156 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.43268712 |
| 157 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41959712 |
| 158 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40667803 |
| 159 | Lysosome_Homo sapiens_hsa04142 | 0.39682557 |
| 160 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.37881285 |

